Use of cyclosporin a in establishing epstein-barr virus-transformed human lymphoblastoid cell lines

Miller, G.; Lipman, M. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc. Natl. Acad. Sci. USA 70: 190–194; 1973.

Gusella, J.; Wexler, N.; Conneally, M.; Naylor, S.; Anderson, M.; Tanzi, R.; Watkins, P.; Ottina, K.; Wallace, M.; Sakaguchi, A.; Young, A.; Shoulson, I.; Bonilla, E.; Martin, J. A polymorphic DNA marker genetically linked to Huntington's disease. Nature 306: 234–238; 1983.

Bird, A.; McLachlan, S.; Britton, S. Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein-Barr virus-induced B-cell lines. Nature 289: 300–301; 1981.

Leapman, S.; Filo, R.; Smith, E.; Smith, P. Differential effects of cyclopsorin A on lymphocyte subpopulations. Transplant. Proc. 13: 405–409; 1981.

Moss, D.; Rickinson, A.; Pope, J. Long-term T-cell-mediated immunity to Epstein-Barr virus in man. III. Activation of cytotoxic T cells in virus-infected leukocyte cultures. Int. J. Cancer 23: 618–625; 1979.